Author

R. Ayerbe Algaba

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Miro Canturri· 3 shared J. Pachon· 3 shared Y. Smani· 3 shared M. E. Jimenez-Mejias· 2 shared A. Vila-Dominguez· 1 shared R. del Toro· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

A. Miro Canturri

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Repurposing of the tamoxifen metabolites to treat methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecalis infections

A. Miro Canturri, A. Vila-Dominguez, R. Ayerbe Algaba, J. Pachon, M. E. Jimenez-Mejias, Y. Smani

This paper shows that tamoxifen metabolites have antibacterial effects against MRSE and vancomycin-resistant E. faecalis, with activity linked to increased membrane permeability.

bioRxiv · May 20, 2021Microbiology

Efficacy of lysophosphatidylcholine as direct treatment in combination with colistin against Acinetobacter baumannii in murine severe infections models

A. Miro Canturri, R. Ayerbe Algaba, M. E. Jimenez-Mejias, J. Pachon, Y. Smani

This study evaluates the efficacy of lysophosphatidylcholine combined with colistin in treating Acinetobacter baumannii infections in mice, showing improved bacterial clearance and survival.

bioRxiv · Dec 2, 2020Microbiology

Tamoxifen repurposing to combat infections by multidrug-resistant Gram-negative bacilli

A. Miro Canturri, R. Ayerbe Algaba, R. del Toro, J. Pachon, Y. Smani

This paper shows tamoxifen reduces inflammation and bacterial load in MDR-GNB infections and has antimicrobial activity via its metabolites.

bioRxiv · Mar 30, 2020Microbiology